[1] Koeck J, AboMadyan Y, Lohr F, et al. Radiotherapy for early mediastinal hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensitymodulated radiotherapy and involvednode radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2012, 83(1): 268276. DOI: 10.1016/j.ijrobp.2011.05.054.
[2] Fiandra C, Filippi AR, Catuzzo P, et al. Different IMRT solutions vs. 3Dconformal radiotherapy in early stage Hodgkin′s lymphoma: dosimetric comparison and clinical considerations[J]. Radiat Oncol, 2012, 7: 186. DOI: 10.1186/1748717X7186.
[3] Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc[J]. Med Phys, 2008, 35(1): 310317. DOI: 10.1118/1.2818738.
[4] 李思源, 徐文贵, 童冠圣, 等. 18FFDG PET/CT对淋巴瘤放化疗后疗效评估及无进展生存期预测的价值 [J]. 国际肿瘤学杂志, 2017, 44(5): 361365. DOI: 10.3760/cma.j.issn.1673422X.2017.05.009.
[5] 谷俊娇, 刘艳艳. 侵袭性非霍奇金淋巴瘤治疗进展[J]. 国际肿瘤学杂志, 2013, 40(9): 705707. DOI: 10.3760/cma.j.issn.1673422X.2013.09.021.
[6] Lamy T, Damaj G, Soubeyran P, et al. RCHOP 14 with or without radiotherapy in nonbulky limitedstage diffuse large Bcell lymphoma (DLBCL)[J]. Blood, 2018, 131(2): 174181. DOI: 10.1182/blood201707793984.
[7] van Nimwegen FA, Schaapveld M, Cutter DJ, et al. Radiation doseresponse relationship for risk of coronary heart disease insurvivors of Hodgkin lymphoma[J]. J Clin Oncol, 2015, 34(3): 235243. DOI: 10.1200/JCO.2015.63.4444.
[8] Ye J, Rao M, Chen F, et al. Evaluation of the dosimetric impact of intrafraction motion and MLC leaf interplay in hypofractionated prostate IMRT and VMAT treatment[J]. Int J Radiat Oncol Biol Phys, 2010, 78(3): S378. DOI: 10.1016/j.ijrobp.2010.07.891.
[9] Jeong Y, Lee S, Kwak J, et al. A dosimetric comparison of volumetric modulated arc therapy (VMAT) and noncoplanar intensity modulated radiation therapy (IMRT) for nasal cavity and paranasal sinus cancer[J]. Radiat Oncol, 2014, 9: 193. DOI: 10.1186/1748717X9193.
[10] Lin CY, Huang WY, Jen YM, et al. Dosimetric and efficiency comparison of highdose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixedfield intensitymodulated radiotherapy[J]. Dis Esophagus, 2014, 27(6): 585590. DOI: 10.1111/dote.12144.
[11] Xu LM, Kang ML, Jiang B, et al. A study of the dosimetric characteristics between different fixedfield IMRT and VMAT in earlystage primary mediastinal Bcell lymphoma[J]. Med Dosim, 2018, 43(1): 9199. DOI: 10.1016/j.meddos.2017.08.010.
[12] Weber DC, Peguret N, Dipasquale G, et al. Involvednode and involvedfield volumetric modulated arc vs. fixed beam intensitymodulated radiotherapy for female patients with earlystage supradiaphragmatic Hodgkin lymphoma: a comparative planning study[J]. Int J Radiat Oncol Biol Phys, 2009, 75(5): 15781586. DOI: 10.1016/j.ijrobp.2009.05.012.
[13] 刘建平, 杨海芳, 王志武, 等. 部分弧容积旋转调强计划在中央型肺癌的应用[J]. 中国医学物理学杂志, 2017, 34(11): 10911095. DOI: 10.3969/j.issn.1005202X.2017.11.003.
|